Niagen Bioscience, Inc. — Director's Dealing 2014

Jan 23, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC.OB)
CIK: 0001386570
Period of Report: 2014-01-21

Reporting Person: Brauser Michael (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-01-21	Common Stock	A	250000	—	Acquired	4769926	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	3721424	Indirect

Footnotes

F1: The restricted shares are awarded to compensate for the efforts on behalf of the Corporation. These shares have certain vesting conditions and shall not vest on or before July 1, 2014.

F2: Indirect beneficial ownership includes, (i) 628,570 Shares held by Grander Holdings, Inc. 401K Profit Sharing Plan of which the Reporting Person is a trustee; (ii) 342,857 Shares held by the Brauser 2010 GRAT of which the Reporting Person is a trustee; (iii) 342,857 Shares held by Birchtree Capital, LLC of which the Reporting Person is the manager; (iv) 1,692,856 Shares held by BMB Holdings, LLLP of which the Reporting Person is the manager of its general partner; and (v) 714,284 Shares held by Betsy Brauser Third Amended Trust Agreement beneficially owned by the Reporting Person's spouse which are disclaimed by him.